Use of 50/50 Premixed Insulin Analogs in Type 2 Diabetes: Systematic Review and Clinical Recommendations

INTRODUCTION: Premixed insulin analogs represent an alternative to basal or basal–bolus insulin regimens for the treatment of type 2 diabetes (T2D). “Low-mix” formulations with a low rapid-acting to long-acting analog ratio (e.g., 25/75) are commonly used, but 50/50 formulations (Mix50) may be more...

Descripción completa

Detalles Bibliográficos
Autores principales: Deed, Gary, Kilov, Gary, Dunning, Trisha, Cutfield, Richard, Overland, Jane, Wu, Ted
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5688993/
https://www.ncbi.nlm.nih.gov/pubmed/29116584
http://dx.doi.org/10.1007/s13300-017-0328-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5688993/
https://www.ncbi.nlm.nih.gov/pubmed/29116584
http://dx.doi.org/10.1007/s13300-017-0328-6

Ejemplares similares